Novavax Inc vs PayPal Holdings, Inc. — how do they compare? Novavax Inc trades at $7.95 (market cap $1.30B), while PayPal Holdings, Inc. trades at $58.23 (market cap $50.53B). The key difference: PayPal Holdings, Inc. is far larger — about 38.9× Novavax Inc's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | PYPL | |
|---|---|---|
Market Cap | $1.30B | $50.53B |
Sector | Health | Financials |
52-Week High | $11.19 | $76.13 |
52-Week Low | $6.22 | $39.08 |
Enterprise Value | $879.40M | $52.68B |
Dividend Yield | — | 0.95% |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →